Atlas Trials

Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

Clinical trial NCT03474094 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03474094
Sponsor
Centre Leon Berard
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Sarcoma,Soft Tissue
Start date
2018-08-01
Primary completion
2026-12-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.